Emerging agents and regimens for polycythemia vera and essential thrombocythemia

por Shallis, Rory M., Podoltsev, Nikolai A.
Publicado 2021

Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period

por Neparidze, Natalia, Wang, Rong, Zeidan, Amer M., Podoltsev, Nikolai A., Shallis, Rory M., Ma, Xiaomei, Davidoff, Amy J., Huntington, Scott F.
Publicado 2022

Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States

por Shallis, Rory M., Wang, Rong, Bewersdorf, Jan P., Zeidan, Amer M., Davidoff, Amy J., Huntington, Scott F., Podoltsev, Nikolai A., Ma, Xiaomei
Publicado 2021

Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea

por Wang, Rong, Shallis, Rory M., Stempel, Jessica M., Huntington, Scott F., Zeidan, Amer M., Gore, Steven D., Ma, Xiaomei, Podoltsev, Nikolai A.
Publicado 2022

Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States

por Bewersdorf, Jan Philipp, Prozora, Stephanie, Podoltsev, Nikolai A., Shallis, Rory M., Huntington, Scott F., Neparidze, Natalia, Wang, Rong, Zeidan, Amer M., Davidoff, Amy J.
Publicado 2022

Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis

por Di, Mengyang, Cui, Can, Kothari, Shalin K., Zeidan, Amer M., Podoltsev, Nikolai A., Neparidze, Natalia, Shallis, Rory M., Wang, Rong, Ma, Xiaomei, Huntington, Scott F.
Publicado 2022

Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence

por Shallis, Rory M., Wang, Rong, Zeidan, Amer M., Huntington, Scott F., Neparidze, Natalia, Stempel, Jessica M., Mendez, Lourdes M., Di, Mengyang, Ma, Xiaomei, Podoltsev, Nikolai A.
Publicado 2023

Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis

por Di, Mengyang, Long, Jessica B., Kothari, Shalin K., Sethi, Tarsheen, Zeidan, Amer M., Podoltsev, Nikolai A., Shallis, Rory M., Wang, Rong, Ma, Xiaomei, Huntington, Scott F.
Publicado 2023

Association Between Ownership of Imaging Equipment and Appropriateness of Staging Positron-Emission Tomography in Non-Hodgkin Lymphoma

por Huntington, Scott F, Zhu, Weiwei, Hoag, Jessica R, Wang, Rong, Zeidan, Amer M, Giri, Smith, Podoltsev, Nikolai A, Gore, Steven D, Ma, Xiaomei, Gross, Cary P, Davidoff, Amy J
Publicado 2019

Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia

por Podoltsev, Nikolai A., Wang, Rong, Shallis, Rory M., Stempel, Jessica M., Di, Mengyang, Neparidze, Natalia, Zeidan, Amer M., Huntington, Scott F., Giri, Smith, Hull, Sarah C., Gore, Steven D., Ma, Xiaomei
Publicado 2023

Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study

por Zeidan, Amer M., Long, Jessica B., Wang, Rong, Hu, Xin, Yu, James B., Huntington, Scott F., Abel, Gregory A., Mougalian, Sarah S., Podoltsev, Nikolai A., Gore, Steven D., Gross, Cary P., Ma, Xiaomei, Davidoff, Amy J.
Publicado 2017

A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia

por Daver, Naval, Salhotra, Amandeep, Brandwein, Joseph M., Podoltsev, Nikolai A., Pollyea, Daniel A., Jurcic, Joseph G., Assouline, Sarit, Yee, Karen, Li, Mengsong, Pourmohamad, Tony, Samineni, Divya, Sumiyoshi, Teiko, Vaze, Anjali, Dere, Randall C., Ma, Connie, Cooper, James
Publicado 2021

Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation

por Romberg, Neil, Al Moussawi, Khatoun, Nelson-Williams, Carol, Stiegler, Amy L, Loring, Erin, Choi, Murim, Overton, John, Meffre, Eric, Khokha, Mustafa K, Huttner, Anita J, West, Brian, Podoltsev, Nikolai A, Boggon, Titus J, Kazmierczak, Barbara I, Lifton, Richard P
Publicado 2014

Follow-up of patients with R/R FLT3-mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial

por Perl, Alexander E., Larson, Richard A., Podoltsev, Nikolai A., Strickland, Stephen, Wang, Eunice S., Atallah, Ehab, Schiller, Gary J., Martinelli, Giovanni, Neubauer, Andreas, Sierra, Jorge, Montesinos, Pau, Récher, Christian, Yoon, Sung-Soo, Hosono, Naoko, Onozawa, Masahiro, Chiba, Shigeru, Kim, Hee-Je, Hasabou, Nahla, Lu, Qiaoyang, Tiu, Ramon, Levis, Mark J.
Publicado 2022

Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Che...

por Perl, Alexander E., Larson, Richard A., Podoltsev, Nikolai A., Strickland, Stephen, Wang, Eunice S., Atallah, Ehab, Schiller, Gary J., Martinelli, Giovanni, Neubauer, Andreas, Sierra, Jorge, Montesinos, Pau, Recher, Christian, Yoon, Sung-Soo, Maeda, Yoshinobu, Hosono, Naoko, Onozawa, Masahiro, Kato, Takayasu, Kim, Hee-Je, Hasabou, Nahla, Nuthethi, Rishita, Tiu, Ramon, Levis, Mark J.
Publicado 2023

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, mult...

por Stahl, Maximilian, Shallis, Rory M., Wei, Wei, Montesinos, Pau, Lengline, Etienne, Neukirchen, Judith, Bhatt, Vijaya R., Sekeres, Mikkael A., Fathi, Amir T., Konig, Heiko, Luger, Selina, Khan, Irum, Roboz, Gail J., Cluzeau, Thomas, Martínez-Cuadron, David, Raffoux, Emmanuel, Germing, Ulrich, Umakanthan, Jayadev Manikkam, Mukherjee, Sudipto, Brunner, Andrew M., Miller, Adam, McMahon, Christine M., Ritchie, Ellen K., Rodríguez-Veiga, Rebeca, Itzykson, Raphaël, Boluda, Blanca, Rabian, Florence, Tormo, Mar, Cruz, Evelyn Acuña, Rabinovich, Emma, Yoo, Brendan, Cano, Isabel, Podoltsev, Nikolai A, Bewersdorf, Jan Philipp, Gore, Steven, Zeidan, Amer M.
Publicado 2020